PT Medikaloka Hermina Tbk

Equities

HEAL

ID1000143100

Healthcare Facilities & Services

End-of-day quote INDONESIA S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
1,090 IDR +0.46% Intraday chart for PT Medikaloka Hermina Tbk -6.03% -26.85%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
PT Medikaloka Hermina Tbk Reports Earnings Results for the Full Year Ended December 31, 2023 CI
PT Medikaloka Hermina Tbk Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Indonesia consortium invests $1.3 bln in new capital RE
Nomura Starts Medikaloka Hermina at Buy With IDR1,980 Price Target MT
PT Medikaloka Hermina Tbk Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Property firm Ciputra to build houses, hotel in Indonesia's new capital RE
Hospital chain Hermina to invest in Indonesia's planned new capital RE
PT Medikaloka Hermina Tbk Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
PT Medikaloka Hermina Tbk Reports Earnings Results for the Full Year Ended December 31, 2022 CI
PT Medikaloka Hermina Tbk Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Indonesia to offer tax holiday to companies investing in new capital RE
PT Medikaloka Hermina Tbk Reports Earnings Results for the Half Year Ended June 30, 2022 CI
PT Medikaloka Hermina Tbk Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
PT Medikaloka Hermina Tbk Reports Earnings Results for the Full Year Ended December 31, 2021 CI
PT Medikaloka Hermina Tbk announces an Equity Buyback for 80,000,000 shares, for IDR 116,000 million. CI
PT Medikaloka Hermina Tbk authorizes a Buyback Plan. CI
PT Medikaloka Hermina Tbk Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
PT Medikaloka Hermina Tbk(IDX:HEAL) added to S&P Global BMI Index CI
PT Medikaloka Hermina Tbk Announces Earnings Results for the Half Year Ended June 30, 2021 CI
PT Medikaloka Hermina Tbk Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
PT MEDIKALOKA HERMINA TBK : Nomura Adjusts Medikaloka Hermina's Price Target to 5,550 Indonesian Rupiahs From 5,200 Indonesian Rupiahs, Keeps at Buy MT
Pt Medikaloka Hermina Tbk Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Quadria Capital Fund II LP managed by Quadria Capital acquired an unknown minority stake in PT Medikaloka Hermina Tbk. CI
PT Medikaloka Hermina Tbk 's Equity Buyback announced on November 16, 2020 has expired, CI
PT Medikaloka Hermina Tbk announces an Equity Buyback for 30,000,000 shares, for IDR 120,000 million. CI
Chart PT Medikaloka Hermina Tbk
More charts
PT Medikaloka Hermina Tbk is an Indonesia-based company, which is engaged in offering general hospital services. The Company is focused on providing services for BPJS patients to support government program in Indonesia. The Company’s services include hospitals, specialties, and featured services. The Company’s hospitals include Hermina Arcamanik, Hermina Balikpapan, Hermina Banyumanik, Hermina Bekasi, Hermina Bitung, Hermina Bogor, Hermina Ciledug, Hermina Cilegon and Hermina Ciputat. In specialties service, the Company provides anatomical pathology, andrology, anesthesiology, cardiology, clinical microbiology, clinical pathology, dentistry, dermatology and venereology, dietetics, emergency medicine, forensic and medicolegal, internal medicine, medical acupuncture, neurology, and surgery. Its subsidiaries include PT Medikaloka Internusa (M Internusa), PT Medikaloka Sejahtera (M Sejahtera), PT Medikaloka Husada (M Husada), PT Medikaloka Daan Mogot and PT Medikaloka Pasteur (M Pasteur).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
1,090 IDR
Average target price
1,680 IDR
Spread / Average Target
+54.13%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. HEAL Stock
  4. News PT Medikaloka Hermina Tbk
  5. PT Medikaloka Hermina Tbk : Nomura Adjusts Medikaloka Hermina's Price Target to 5,550 Indonesian Rupiahs From 5,200 Indonesian Rupiahs, Keeps at Buy